Clinical Scientist in microbiology. Interests: AMR; epidemiology of Gram-negatives; diagnostics for resistance detection. Views my own. @[email protected]
Come join us in @UKHSA’s Antimicrobial Resistance and Healthcare Associated Infections Reference Unit - the UK’s national reference laboratory for #AntimicrobialResistance
https://t.co/1OTRC6NbFl
🆕💫Antimicrobial Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia Isolates /Europe, Asia,Latin America (2018–2023)
1,287 clinical isolates
71 medical centres 🌎
Aztreonam-avibactam most active 99.5%
Bactrim 95.6/96.3% S per CLSI/EUCAST
https://t.co/iFkoaLYdHJ
@vivax74@drtimothyli We get a number of requests for testing at the ref lab but reject the request with an explanatory report comment to hopefully put off further requests. There’s a lot of misunderstanding about use of the newer antibiotics despite these helpful tables…
New from @UKHSA AMRHAI Reference Unit and AMR & HCAI Division colleagues:
A case of penicillin-resistant group B Streptococcus isolated from a patient in the UK https://t.co/dvvMGrhVc7
#AntimicrobialResistance
The Sanger Prize Competition 2025 - calling for undergraduate students in LMICs
The winner will be offered a 3month internship with travel, living and research expenses are all covered by the award. https://t.co/ho1QSRTl5Q #sangerinstitute
PUBLISHED: The 2023-24 English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report https://t.co/cyE1WCdprs
Register to find out more about the findings in the report at the webinar we are hosting on 20th November: https://t.co/PCrqcNYAfX
The increasing report of NDM-producing E. coli isolates that are resistant to either aztreonam-avibactam and/or cefiderocol is major source of concern!
Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli #idxposts
https://t.co/Gm1jXMxbaB
Come join us at the UK’s national reference lab for AMR and HCAIs - permanent AfC8b Clinical Scientist role leading Staph and Strep Service.
Apply here: https://t.co/Hi43EiC31U
We are running a massive online open course on AMR databases starting end of the month. Its completely free, study at your own pace and its ~15 hours overall over the 3 weeks (although you can finish any time in a year). Please spread in your networks! https://t.co/n6LU8VDeTw
Carbapenemase detection is best via PCR or LFD but interpretive reading of antibiograms can help predict carbapenemase type #WAAW#AntimicrobialResistance https://t.co/igQMxmXpD9
Exciting times! A big paper I was involved in has dropped @NatureMicrobiol.
100 cases of phage therapy facilitated by a Belgian consortium showing 77.2% clinical improvement. I will go through the results below put please read 👇
https://t.co/bZp80KtBvQ
Join us for an interesting webinar on the challenge of manufacturing and procuring #antibiotics responsibly 🌍
📅5 June, 12-1pm BST
🔗Free registration: https://t.co/dKEyAIPSLd
@BSI_UK@ShionogiUS
Responsibilities to include technical work in the in-vitro evaluation of:
- novel antimicrobial
- antimicrobial susceptibility testing kits
- molecular testing kits/systems for detecting resistance determinants
- or surveillance of antimicrobial resistance.